BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32507909)

  • 1. Hemangioblastoma and von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment.
    Klingler JH; Gläsker S; Bausch B; Urbach H; Krauss T; Jilg CA; Steiert C; Puzik A; Neumann-Haefelin E; Kotsis F; Agostini H; Neumann HPH; Beck J
    Childs Nerv Syst; 2020 Oct; 36(10):2537-2552. PubMed ID: 32507909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic irradiation for optic nerve hemangioblastoma associated with Von Hippel-Lindau disease: a case report and literature review.
    Lestrovaya AI; Golanov AV; Zolotova SV; Antipina NA; Kuznetsova AS
    Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(5):78-84. PubMed ID: 37830472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease.
    Daniels AB; Chang EY; Chew EY; Gombos DS; Gorin MB; Shields CL; Wiley HE
    Ophthalmology; 2024 May; 131(5):622-633. PubMed ID: 38092079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation in Chek2 triggers von Hippel-Lindau hemangioblastoma growth.
    Cabrera-Montes J; Aguirre DT; Viñas-López J; Lorente-Herraiz L; Recio-Poveda L; Albiñana V; Pérez-Pérez J; Botella LM; Cuesta AM
    Acta Neurochir (Wien); 2023 Dec; 165(12):4241-4251. PubMed ID: 37843608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological applications of belzutifan in von Hippel-Lindau disease.
    Zhang Y; Nguyen CC; Zhang NT; Fink NS; John JD; Venkatesh OG; Roe JD; Hoffman SC; Lesniak MS; Wolinsky JP; Horbinski C; Szymaniak BM; Buerki RA; Sosman JA; Shenoy NK; Lukas RV
    Neuro Oncol; 2023 May; 25(5):827-838. PubMed ID: 36215167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastoma.
    Park S; Chan CC
    Histol Histopathol; 2012 Aug; 27(8):975-84. PubMed ID: 22763871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and surveillance recommendations for central nervous system hemangioblastomas in pediatric patients with Von Hippel-Lindau disease.
    Knoblauch AL; Blaß BI; Steiert C; Neidert N; Puzik A; Neumann-Haefelin E; Ganner A; Kotsis F; Schäfer T; Neumann HPH; Elsheikh S; Beck J; Klingler JH
    J Neurooncol; 2024 Apr; ():. PubMed ID: 38647646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular clusterin expression in von Hippel-Lindau disease.
    Zhou M; Shen D; Head JE; Chew EY; Chévez-Barrios P; Green WR; Chan CC
    Mol Vis; 2007 Nov; 13():2129-36. PubMed ID: 18079682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States.
    Jonasch E; Song Y; Freimark J; Berman R; Nguyen H; Signorovitch J; Sundaram M
    Orphanet J Rare Dis; 2024 Feb; 19(1):73. PubMed ID: 38365728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Radiosurgery for Cranial and Spinal Hemangioblastomas: A Single-Institution Retrospective Series.
    Yoo KH; Park DJ; Marianayagam NJ; Gu X; Pollom EL; Soltys SG; Chang SD; Meola A
    Neurosurgery; 2024 Mar; 94(3):630-642. PubMed ID: 37967154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of cerebellar hemangioblastoma simulated brain metastasis shown by magnetic resonance imaging.
    Xue J; Mo C
    Medicine (Baltimore); 2024 Feb; 103(6):e37162. PubMed ID: 38335432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive resection of spinal hemangioblastoma: feasibility and clinical results in a series of 18 patients.
    Krüger MT; Steiert C; Gläsker S; Klingler JH
    J Neurosurg Spine; 2019 Aug; 31(6):880-889. PubMed ID: 31398701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic hemangioblastomas are characterized by cryptic VHL inactivation.
    Shankar GM; Taylor-Weiner A; Lelic N; Jones RT; Kim JC; Francis JM; Abedalthagafi M; Borges LF; Coumans JV; Curry WT; Nahed BV; Shin JH; Paek SH; Park SH; Stewart C; Lawrence MS; Cibulskis K; Thorner AR; Van Hummelen P; Stemmer-Rachamimov AO; Batchelor TT; Carter SL; Hoang MP; Santagata S; Louis DN; Barker FG; Meyerson M; Getz G; Brastianos PK; Cahill DP
    Acta Neuropathol Commun; 2014 Dec; 2():167. PubMed ID: 25589003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal leptomeningeal hemangioblastomatosis occurring without craniospinal surgery in von Hippel-Lindau disease.
    De Jesus O; Rosado-Philippi J
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 36038156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease.
    Albiñana V; Escribano RMJ; Soler I; Padial LR; Recio-Poveda L; Villar Gómez de Las Heras K; Botella LM
    Orphanet J Rare Dis; 2017 Jun; 12(1):122. PubMed ID: 28662711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual Spinal Foraminal Hemangioblastoma With Prominent Arteriovenous Shunt.
    Santos M; Marussi VH; Campos CM; Doria-Netto HL; Doria-Netto RH; Chaddad-Neto F; Amaral LLF
    Cureus; 2023 Sep; 15(9):e46205. PubMed ID: 37905285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Hippel-Lindau Disease.
    Findeis-Hosey JJ; McMahon KQ; Findeis SK
    J Pediatr Genet; 2016 Jun; 5(2):116-23. PubMed ID: 27617152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease.
    Chan CC; Chew EY; Shen D; Hackett J; Zhuang Z
    Mol Vis; 2005 Sep; 11():697-704. PubMed ID: 16163267
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.